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ABSTRACT
BACKGROUND AND OBJECTIVES
Maintenance of airway is an integral part  of general anaesthesia.
Various airway devices are used for this purpose. Hemodynamic changes are
major hazards of general  anaesthesia with endotracheal intubation and are
probably generated by direct laryngoscopy and endotracheal intubation.
Supraglottic airway devices have been widely used as an alternative to
tracheal intubation during general anaesthesia. Laryngeal mask airway is a
Supraglottic airway device with an inflatable cuff forming a low pressure seal
around the laryngeal inlet and permitting ventilation .The I-gel is a novel
Supraglottic airway device made of thermoplastic elastomer which is soft gel
like and transparent. It does not have an inflatable cuff.
In view of this, the present study was undertaken to compare the
performance of two Supraglottic airway devices classic Laryngeal Mask
Airway and I-gel in anaesthetised spontaneously breathing patient
undergoing Elective  minor gynaecological surgeries under general
anaesthesia.
METHODOLOGY
Eighty patients scheduled for various elective minor gynaecological
surgeries, under general anaesthesia who meet the inclusion criteria were
included in these study and were randomly divided into two groups with 40
patients in each group. In group I classical LMA was used and in group II , I-
gel was used. Both the devices were compared in relation to the ease of
insertion, number of insertion attempts, time of insertion, airway leak
pressure, gastric insufflation, hemodynamic changes, intra and postoperative
complications.
RESULTS
             There was no statistically significant difference between the devices
with respect to ease of insertion, number of attempts of insertion. Gastric
insufflation.  The mean time of insertion for I-gel was 22.82±4.30 seconds
which was significantly shorter compared to c LMA with mean insertion time
of 25.88±4.32 seconds (P = 0.002). The mean airway leak pressure with I-gel
was significantly higher as compared with c LMA (23.82±2.47 and
19.12±2.23 cm H2O, respectively p=0.00). There were no statistically
significant differences in hemodynamic changes and postoperative
complication between the devices.
INTERPRETATION AND CONCLUSION
Both I-gel and classic LMA are easy to insert and provide an effective
airway during spontaneously breathing patients under general anaesthesia.
But insertion of I-gel was easier and more rapid than insertion of c-LMA and
also I-gel providing a better airway sealing pressure as compared to c-LMA.
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INTRODUCTION
1INTRODUCTION
The supraglottic airway device is a novel device, which fills the gap in
airway management between tracheal intubation and use of face mask. Dr.Archie
Brain, a british anaesthesiologist, for the first time introduced the laryngeal mask
airway in 1983, designed to be positioned around the laryngeal inlet that could
overcome the complication associated with endotracheal intubation and yet, be
simple and atraumatic to insert24.   Careful observations and clinical experience
have lead to several refinement of Brain’s original prototype leading to
development of newer supraglottic airway devices with better features for airway
maintenance24. These airway devices can be grouped in to (i) intraglottic (ii)
extraglottic. As time went on , additional devices were added to the LMA family to
satisfy specific needs and a number of other devices were developed. There are a
large number of supraglottic airway devices, some of which appear similar to the
LMA family and others that work under a different concept35.
When    intubation  is  done  with  help  of   laryngoscopy  ,there  will  be
stimulation of sympathetic system result in adverse events    in the form of raised
heart rate, increased  arterial pressure ,dysrhythmias ,increased  tension in cranial
cavity . These adverse events are well tolerated by healthy individuals, but in high
risk peoples like hypertensive, ischemic heart disease patients, cerebro vascular
insufficient persons may be harmful.22. This laryngoscopic reaction in such
2individuals may predispose to development of pulmonary edema, myocardial
insufficiency and cerebrovascular accident8,25.   Supraglottic  airways  can be used
in surgery which are done under  general anaesthesia  in order to avoid these
complications. The gold standard supra glottis airway devices is LMA –classic. It
was used in practice since 1983 .
The laryngeal mask airway is a supraglottic airway device with an inflatable
cuff   which produces a low pressure seal around the inlet of larynx  and helping
ventilation24. The I- gel is a new one which is also  supraglottic airway .It does not
have  inflatable  cuff  .  Instead  of  cuff  it  has  soft  gel  like  material  which  is
transparent thermo softening plastic.  There will be a separate port for  Ryles   tube
insertion. 7 When compared to endotracheal intubation these devices will not give
protection to lungs from aspirated food particles completely. These laryngeal mask
airway carries 0.002% aspiration risk .This  is equal to  endotracheal ventilation in
elective patients21.
The newer supraglottic airway device, I-gel was introduced by Dr.
Muhamad Aslam Nasir  in 2007.   The  advantages of  I-gel   are insertion is  easy ,
tissue compression is minimal , and an inbuilt biteblock17.
Many studies have been done to compare I-gel with Proseal LMA. But not
many studies have been done to compare the clinical uses of the two supraglottic
3airway devices namely I-gel and classical LMA. Hence, this study was undertaken
in Institute of Obstetrics and Gynecology, Rajiv Gandhi Government General
Hospital, Chennai during the period August 2014 to September 2014. In this study,
we compare these two supraglottic `airway devices in relation to ease of insertion,
number of insertion attempts, time for insertion, airway leak pressure,
hemodynamic changes, intra and postoperative complications in anaesthetized
spontaneously breathing patients undergoing elective minor gynaecological
surgeries under general anaesthesia.
AIM  AND OBJECTIVES
OF THE STUDY
4AIM & OBJECTIVES
AIM:
A Prospective Randomized control study to compare the two supraglottic
airway devices classic -LMA and I-gel in anaesthetized spontaneously breathing
adult patients posted  for minor gynaecological surgeries  under general
anaesthesia at Institute of Obstetrics and Gynecology (MMC, Chennai).
Primary objectives:
1) Ease of insertion
2) Time taken for insertion
3) Number of  insertion attempts
4) Leak pressure
5) Gastric insufflation
6) Hemodynamic parameters
Secondary objectives:
       Adverse events:
-  Lip, tongue, dental injuries
-   Post operative hoarseness of voice, dysphagia, sore throat.
BASIC ANATOMY
5BASIC  ANATOMY 33,34,
Anatomical structures   relevant to laryngeal mask airway space include the
mouth, Oropharynx and  Laryngopharynx.
Mouth
The  roof  of  the  mouth  formed by vaulted palate. Anterior  part is formed
by hard palate and the  posterior part is formed by soft  palate. The shape of hard
palate is such that a food bolus is directed into the oropharynx inlet with the
stiffened soft palate shielding the nasopharynx. There might  be some difficulty in
passing the laryngeal mask airway into oropharynx, if the angle of approach
between the hard palate and posterior oropharyngeal wall is < 90degree. Mouth
opening is essential for laryngeal mask airway placement. The normal distance
between the upper and the lower incisor teeth in adult patients with normal
temporomandibular  joint  function is 47 mm with a range of 31-55 mm. At least
12mm mouth opening is needed for inserting  laryngeal mask airway.
6Figure 1: anatomy of oral cavity
TONGUE
Tongue is a muscular organ situated in the floor of the mouth. It has an oral
part that lies in the mouth and a pharyngeal part that lies in the pharynx. The oral
and pharyngeal parts are separated by a V shaped sulcus, the sulcus terminalis.
ORAL PART
Placed on the floor of the mouth. The margins are free and in contact with
gums and teeth.
7PHARYNGEAL PART
The posterior part of the tongue is connected to epiglottis by  the median
glossoepiglottic fold and the right and left glossoepiglottic folds. Vallecula is a
pouch like area situated on either side of the median fold. The lateral folds separate
the vallecula from piriform fossa.
PHARYNX
The pharynx extends from posterior aspect of the nose at the base of the
skull down to the level of lower border of cricoid cartilage where it becomes
continuous with Oesophagus, and the respiratory tract through larynx. The soft
palate partially divides the pharynx into two, an upper nasopharyngeal portion and
a lower Oropharyngeal portion. Pharynx is partially divided by the soft palate into
1)  Nasopharynx 2) Oropharynx 3) Laryngopharynx
1) Nasopharynx
This is First  part of pharynx situated posterior to  the nose, and superior to
the lower border of soft palate. The roof and posterior wall form a continuous
slope, opposite the posterior part of body of sphenoid, basiocciput and anterior
arch of atlas. Under the mucous membrane, opposite the basiocciput is a collection
of lymphoid tissue called nasopharyngeal tonsil or adenoids.
82) Oropharynx
It is the middle part of pharynx, starts below the soft palate and extends to
hyoid bone to continue as laryngopharynx at the level of upper border of the
epiglottis. Behind, it is supported by the body of the axis vertebra. In the lateral
walls of oropharynx are situated the tonsillar pillars or fauces. The anterior pillar
contains glossopharyngeal muscle and the posterior pillar contains palatoglossus
muscle.
3) Laryngopharynx
It is also called hypopharynx. It is located posterior to the larynx. It starts
from upper border of the epiglottis and ends in lower border of the cricoid
cartilage. The lateral wall presents a depression called piriform fossa, one on each
side of the inlet of larynx.
The fossa is bounded medially by aryepiglottic fold and laterally by thyroid
cartilage and thyrohyoid membrane. Beneath the mucosa of the fossa, there lies the
internal laryngeal nerve. Removal of the foreign bodies from the piriform fossa
may damage this nerve.
9Figure 2: anatomy of pharynx
Fig 3:  Side view illustrating the 3 constrictors of the
pharynx and their attachments.
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Figure 4: anatomy of larynx
BASIC PHARMACOLOGY
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BASIC PHARMACOLOGY36,37,39
GLYCOPYRROLATE
Structure:
An anticholinergic which acts by antagonistic action over muscarinic
acetylcholine receptors. It acts as a Competitive antagonistic action.
It  was synthesized in 1960 .It  is  a  Synthetic  quaternary amine.  It  is  formed
by combination of mandelic acid plus organic base (tropine/scopine/N-methylated
derivation of atropine). Anticholinergic drugs have cationic portion which fits in
muscarnic receptor
Mechanism of action:
It is  highly selective competitive antagonist at all muscarnic receptors.
Muscarnic receptors are G-protein coupled receptors whose second messenger
varies accordingly .Anti sialogogue property due to blockage of M3 receptors
present over respiratory tract & salivary gland.
Pharmacokinetics:
It is incompletely absorbed from intestinal  tract due to complete ionisation.
Onset  of action in -IV-(slower compared to atropine): 2 to 3 min.
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Duration of action:
Parenteral  : Vagal block (2-3 hours), Inhibition of salivation -7 hours
Oral          :  Anticholinergic effect (8-12 hours)
Volume of distribution :
Adult-1.3-1.8 lit/kg
Children-0.2-0.62 lit/kg
Clearance:
Clearance of glycopyrrolate is rapid than atropine 1.3 m vs 2.3 m (for
atropine). 80 % of drug is eliminated unchanged via urine. Elimination is
prolonged in uremic patient..
Uses :
1. Anti  sialogogue  property  due  to  M3 blocking property . used as
premedication . Potent inhibitor of salivary and respiratory secretion.Do not
cross BBB/placental barrier. So it does not cause sedation which is
predominantly seen in scopolamine.
2. Pharmacologic enhanced antagonist of non-depolarising  muscle relaxants
with neostigmine requires concomitant administration of glycopyrrolate
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3. Because ,this drug acts over M2 receptors on SA node & causes higher in
HR (this higher in HR not seen via IM injection )
4. This compensates the bradycardia caused by neostigmine that may
significantly leads to cardiac arrest
5. Decreased acid secretion in stomach & so may be used for peptic ulcer.
Dosage:
5 to 10 mic/kg, Upto 0.2 to 0.3mg in adults, Package 0.2 mg /ml, Tab 1.5 mg
Side effects:
Dryness of mouth and skin,  Anhydrosis, Flushing , Blurring of vision
Constipation, Urinary retention, Palpitation, Cyclopegia, Hyperthermia
(especially in infants), Cardiac arrhythemias.
Special considerations:
? For glaucoma patients
? For parturients (pregnancy-placed under category B
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SEVOFLURANE
Sevoflurane was Synthesised more than 40 years ago at Travenol laboratory
.But it was introduced only in the late 1980s though its recovery is rapid because of
its unstability in presence of sodalime.
Introduction:
It is a fluorinated methyl isopropyl ether.
Partition co-efficient:
Describes relative affinity of an anaesthetic for two phases when an
equilibrium has been achieved.
Blood gas coefficient- for sevoflurane 0.65
TABLE : 1
Blood
gas
Brain-
blood
Liver
blood
Kidney
blood
Muscle
blood
Fat-
blood
Sevoflurane 0.65 1.7 1.8 1.2 3.1 4.8
1. Non pungency, minimal odour
2. Rapid rise in alveolar anaesthetic concentration & low blood gas partition
co-efficient in low blood solubility-makes induction & recovery faster
3. When compared to isoflurane ,recovery is 3 to 4 minutes faster.
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Inhalational induction:
4% to 8% sevoflurane in 50% mixture of N2O & O2 can be achieved in 1
minute
Biodegradation:
It is metabolised by liver microsomal enzyme p 450
It does not form aryl halide in this regard, it differs from rest of the flurane .
so no hepatotoxicity & cross-sensitivity seen in case of sevoflurane.
Effects of sevoflurane over systems:
EEG:
< 0.4 MAC  – higher frequency & voltage
At 0.4 MAC – cerebral metabolic O2 begin to decrease abruptly. -amnesia occur.
Transition from wakefulnese to unconsciousnese
1 MAC  - Frequency decrease & voltage increase
Sevoflurane - Dose  related EEG changes
Non anaesthetic MAC concentration - initial increase in frequency &
lowering of voltage.
At anaesthetic MAC -  increase voltage
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Seizure activity - in presence of deep level of anaesthesia / hypocapnia /
auditory stimulation- do not produce evidence of convulsive activity in EEG
It suppresses convulsive activity induced with  lidocaine.
Mental function and awareness:
Significant pharyngeal dysfunction occur at 25% MAC awake
To restore pharyngeal reflexes-90% of elimination is required.
Cerebral blood flow:
Usually normocapnia with >0.6 MAC – volatile anaesthetic produce cerebral
vasodilatation ,decrease cerebral vascular resistance & dose depedent increase in
CBF ,Sevoflurane produces  dose depedent cerebral vasodilatory effect and
decreases  Cerebral metabolic O2 requirement.
Circulatory effects:
Mean arterial pressure-  fall in pressure principally due to decrease in
systemic vascular resistance
Heart rate            -   increase in HR (seen only in > 1.5 MAC)
Cardiac output     -   decrease (At  1 & 1.5 MAC
- At 2 mac- cardiac out put recovers to nearly to conscious level
Right arterial pressure – no change
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Cardiac dysrythmia – minimal to non existing prolongation  with sevoflurance.
Accessory pathway conduction – sevoflurane  no effect on atrioventricular
/accessory pathways-acceptable drug for patients undergoing ablative produces.
Cardiac protection:
Patient receiving sevoflurance for cardiac surgery has  less myocardial
injury during first 24 hrs postoperative period than patient receiving Propofol
cardio protectiveness of sevoflurane is seen when it is administered throughout
surgery than as a part of surgery.
Ventilation effects:
Ventilator response to CO2: Dose dependent depression of ventilation
characterised by decrease in ventilator response to CO2 &  increase in PaCO2
,Profound decrease in ventilation leading to apnoea but  1.5 & 2 mac leads to
increase PaCO2..
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Ventilatory response to hypercapnia:
Sevoflurance induced decrease in hypoxic responsiveness are not different in
men & women. It is usefull in thorasic surgery as it is a potent bronchodilator
Airway resistance and irritability:
Risk factors for branchospasm
Preoperative respiratory track infection, Endotracheal intubation ,COPD
In patient with COPD, sevoflurane cause bronchodilatation & decrease
airway resistance (after intubation in patient without asthma)
? At 1 MAC ,sevoflurane suppress response to tracheal intubation
? No irritant property
? But exposure of sevoflurane to dessicated CO2 absorbent’especially
with KOH result in production of toxic gases leading to airway
irritation & impared gas exchange..
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PROPOFOL
STRUCTURE OF PROPOFOL:
Propofol consists of phenol ring substituted with two  isopropyl  groups.  It
is not water soluble.1%  Propofol present as oil-in – water emulsion containing
10% soyabean oil ,2.25% glycerol ,1.2%purified egg phosphatide/egg lecithin.It is
not  contraindicated to use in egg allergic individuals because egg allergies
involves reaction to egg white( egg albumin),here  egg lecithin extracted from egg
yolk.
COMMERCIAL PREPARATION OF PROPOFOL:
Current formulation contains soyabean oil as oil phase and egg lecithine as
emulsifying agent which is composed of long chain triglycerides .This favours
bacterial growth and also increase plasma triglyceride level when there is
prolonged intravenous infusion .As it favours contaminations ,the opened vial has
to be used  within 6 hrs to avoid this ,preservative such as 0.005% disodium
edetate or 0.025% sodium metabisulfate is added which retards the growth of
microbes.
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MECHANISM OF ACTION:
GABA is the principal inhibitor neurotransmitter in the CNS. Propofol is
relatively selective modulator of GABAA  receptors therby facilitating inhibitory
neurotransmission.   Interaction  of  Propofol  with  specific  components  of  GABAA
receptors decreases the rate of dissociation of inhibitory neurotransimitter there by
increasing the duration of GABA activated opening of cl-  channel ,there by
increasing the transmembrane conductance of cl - channel resulting in
hyperpolarisation of post synoptic  cell membrane and functional inhibition of post
synaptic neuron .Propofol action not reversed by BZD antagonist flumazenil.
PHARMACOKINETICS:
Propofol has rapid onset of action due to very short distribution half life (2-8
min) following single bolus  .Because of it’ s rapid and complete awakening
,causes this Propofol to use in day care surgery .Age is a key factor  determining
Propofol infusion  rates .For elderly patients ,smaller induction dose is
recommended because of their small volume of distribution.To provide controlled
target infusion of  Propofol Diprifusor is used for which patients age ,weight ,and
desired target concentration has to be entered..
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BIOTRANSFORMATION:
Clearance of Propofol from plasma exceeds hepatic blood flow indicating
the extra hepatic  metabolism. Hepatic oxidative metabolism by cytochrome p 450
is important in removing this drug. By extensive hepatic metabolism this drug
converted to inactive water soluble sulfate and  glucuronic acid metabolities that
are excreted by kidney .It also undergo hydroxylation to form 4  -hydroxy
Propofol which is then conjugated with glucuronides or sulfate. 4 –Hydroxy
Propofol has one third of  hypnotic activity of Propofol..About less than 0.3% of a
dose is excreated  unchanged in urine  Apart from hepatic metabolism
,extrahepatic metabolism  is due to pulmonary uptake and renal clearance.
PULMONARY UPTAKE OF PROPOFOL:
In lungs Propofol transformed to 2,6 diisopropyl1,4 quiniol and  then
released in to circulation .Pulmonary uptake influences initial uptake of Propofol
.Human  kidneys  plays  an  important  role  in  the  elimination   of
Propofol.Glucuronidation is the major metabolic pathway for Propofol  and UDP
glucuronyl transferase are expressed in brain and  kidney.
ELIMINATION HALF LIFE OF PROPOFOL is 0.5 to 1.5 hrs .
VOLUME OF DISTRIBUTION  is 3.5 to 4.5 liter per kilo gram
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CLEARANCE is 30 -60 ml /kg/min
Context  sensitive half time for Propofol infusion lasting up to 8 hrs is <40
mins. Though its eliminated by liver and kidney there is no evidence of impaied
metabolism by cirrhosis of liver /renal dysfunction patients.
CLINICAL USES:
Become the induction of choice when complete and rapid awakening is
desirable .
It  become  a  part  of  conscious  sedation  or  as  a  part  of  balanced   or   total
intravenous anaesthesia.
Dosage of Propofol:
For induction of anaesthesia  ;1.5 to 2.5 mg / kg( iv )with blood level  2 to 6
µg/ml. Awakening occurs at concentration of 1 to 1.5 mic /ml
Intravenous sedation ;25 – 100 µg /kg /min.
Maintenance of  anaesthesia ;100-300µg/kg /min
Anti emetic effect ;10 mg iv
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EFFECT ON ORGAN  SYSTEM:
CENTRAL NERVOUS SYSTEM:
Propofol decreases CMRO2,cerebral blood flow, intracranial presser. Large
doses of Propofol decreases systemic blood presser there by decreases cerebral
perfusion pressure. Cerebral auto regulation in responses to change in systemic
blood presser and reactivity of cerebral blood flow to change in Paco2are not
affected .Propofol produce cortical EEG changes ,which in high doses  is able to
produce burst suppression .Awake craniotomy which is performed for the
management of refractory epilepsy , Propofol is used as it does not interfere with
electro corticographic recordings . But Propofol has to be discontinued 15 min
before the recording. Propofol produces the memory impairment as midazolam
whereas thiopentone has mild effect , fentanyl no effect over memory..
CARDIOVASCULAR SYSTEM:
Propofol produces decrease in systemic blood pressure .This decrease in
blood pressure due to decrease in cardiac output and ,decrease in SVR. The
decrease in SVR is due to inhibition of sympathetic vasoconstrictor nerve activity.
Decrease in cardiac output is due to negative inotropic effect resulting from
decrease in intracellular Ca2+ availability  secondary to inhibition of trans –
sarcolemmal  Ca2+influx. Propofol effectively blunts the hypertensive responses
occurs due to endotracheal intubation, direct laryngoscopy  and LMA .It also blunt
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the increase in epinephrine concentration which occur as a result of sudden
increase in desflurane at a Propofol concentration of 2 mg /kg iv. The fall in blood
pressure due to induction by Propofol is exaggerated in  old age ,compromised left
ventricular function due to coronary artery disease.The pressure response to
ephedrine is augmented by Propofol.
HEART RATE:
Bradycardia and asystole has been observed in patients receiving induction
with Propofol. This is due to decrease in sympathetic  activity resulting in
predominance of parasympathetic action .Propofol does not alter sinoatrial, AV
node in normal patients or patient with wolff-parkinson syndrome.so Propofol is
recommended during ablative procedures and while using Propofol  there is
disappearance of delta wave in EEG. Bradycardia following Propofol
administration does not respond to atropine. so treatment of choice for Propofol
induced bradycardia is isoproterenol.
LUNGS:
Propofol produces dose dependent depression of ventilation with apnoea
occuring   in 25%to 35%of patients.
Propofol decrease tidal volume ,decreases respiratory rate ,decreases
ventilatory  responses  to CO2, arterial hypoxemia.
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At sedative concentration Propofol depress ventilator responses to
hypercapnia, due to action central chemoreceptors. Hypoxic pulmonary
vasoconstriction seem to  remain intact in patient receiving Propofol..
HEPATIC AND RENAL FUNCTION:
Normally ,there is no hepatic or renal injury. But when there is
accompanying lactic acidosis  ,bradyarrhythemia, rabdomyolysis with prolonged
infusion of Propofol produces hepatocellular damage.  Infusion of Propofol leads
to green colour urine reflects presence of phenol in urine .In gout ,urinary uric acid
excretion is increased presenting as cloudy urine and it does not indicate the
alteration in renal function.
ADVERSE EVENTS:
ALLERGY:
Di-isopropyl side chain and phenol nucleus  are responsible for allergy.
LACTIC ACIDOSIS/ PROPOFOL INFUSION SYNDROME:
Pediatric and adult patients receiving prolonged high dose infusion of
Propofol (>75 mic/kg/min ) for more than 24 hrs, develop  lactic acidosis(increased
anion gap ).Initially –discontinuation of  Propofol  and extra corporeal membrane
oxygenation has to be done.
SUPRAGLOTTIC
AIRWAY DEVICE
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SUPRAGLOTTIC  AIRWAY  DEVICES35,38
The LMA was conceived and designed by Dr. Archie Brain in UK in 1981
and following prolonged research was released in 1988. Dr. Archie Brain worked
on the idea of decreasing the size of anaesthetic mask so that instead of applying it
over the face it could be applied over the laryngeal opening. The first independent
clinical trial of LMA was carried out at north wick park hospital in 1987 and
within 1 year the design was finalized and four sizes were available by September
1990 all British hospitals performing operations add LMA on their anaesthesia
machines.  But this device was also not full proof against complications like
aspiration.
CLASSIC LMA:
The classic LMA was invented by Dr. Archie brain in the year 1981 and
introduced in 1988.
The classic LMA is made from medical grade silicone. It consists of a
curved tube connected to an elliptical spoon shape mask at a 30 degree angle.
There are 2 flexible vertical bars at the entry of the tube into the mask to prevent
obstruction of the tube by the epiglottis. The mask is surrounded by an inflatable
cuff. An inflation tube and self-sealing pilot balloons are attached to the proximal
wider end of the mask. A black line running longitudinally along the posterior
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aspect of the tube helps to orient it after placement. At the machine end of the tube
it has a standard 15mm connector.
Fig  5 : Classic  LMA
The classic LMA is available in 8 sizes and the choice of the correct size is
according  to  the  patient’s  weight.  When  there  is  doubt,  a  larger  than  the  smaller
size should be chosen for the first attempt.
Indications :
1) As an alternative to mask while giving anaesthesia.
2) Can be used in minor surgeries.
3) As a rescue device in failed intubation.
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4) As an  emergency airway management in CPCR.
5) As a tool for airway management in the pre hospital setting in
patients in whom positioning or prolonged extrication does not allow
for endotracheal intubation.
6) As a conduit for intubation for especially when direct laryngoscopy is
not successful.
CONTRAINDICATIONS: In patients with:
1. Restricted mouth opening.
2. Complete upper airway obstruction.
3. Increased risk of aspiration.
4. Suspected or known abnormalities of supraglottic anatomy.
5. Need for higher airway pressures.
INSERTION:
Standard Technique
LMA  is  inserted  with   a  fully  deflated  cuff  through   midline  or   diagonal
approach  with patients in sniffing position .The head is stabilized with the  non
inserting hand  and mouth  can be opened by an assistant. The LMA is held like a
pen with the index finger  over the  shaft at its junction with the cup. The aperture
of the cup should face anteriorly and the tip is  placed over hard plate  with shaft
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parallel to the floor .If jaw is held open it should be released before insertion .In
case of restricted mouth opening, LMA is passed  behind the molar teeth  into the
pharynx .The LMA is held with index finger and pressed over the hard palate .
Resistance is felt if the tip of the cup is folded on itself or if it faces any irregularity
in its passage. If such a resistance is felt LMA should   be withdrawn  and
reinserted .The course of  LMA  changes as it slides in to the  pharynx ,the index
finger  is advanced further with arm in  pronation .The black line on the LMA shaft
is always positioned mid line and any change of this position denotes misplaced.
Lateral approach can also be used especially in high arched palate patients .Always
ensure  that  the  tip  of  cuff  is  flat  and  well  approximated  with  the  palate.  If  initial
insertion not fruitful ,different maneuvers can be tried .they are; (i) insertion from
the angel of mouth    (ii) pulling out the tongue anteriorly (iii)giving jaw thrust
(iv)adjusting the head position (v) rotating the cuff to 1800 when inside
oropharynx.(vi)using  CPAP  while inserting . (vii) slight lateral rotation, (viii)
partial cuff inflation ,(ix) introducing a finger  posteriorily to the cup as a glide (x)
using laryngoscopy and  stylete  for insertion .The cup should rest on the floor of
hypopharynx with sides facing pyriform fossa and superior border of the cup
facing posterior most tongue .The epiglottis lies over the cup and sometimes the
oesophagus lies within the rim of the cup.
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Using the LMA family :
Always keep  LMA  of 3 sizes use- one the chosen size and one smaller and
one larger sizes. Use only air to inflate the pilot balloon,  using  a Propofol  or
other organic substance contaminated syringe cause damage to the LMA.
Pre- use inspection:
Visual inspection:
Look  at  the  tube  for  any  change    in  colour,  foreign  body  ,   cuts  ,tears
.Examine the cup and its aperture for any damage  or foreign body .The connector
is checked for its tight fitting .
Deflation/inflation
(i) Deflate the cup gently and look for re inflation even after removal of
syringe from the inflation valve .If it inflates it suggest damaged valve or
leaking cuff.
(ii) Inflate the cuff with double the volume recommended and look whether
the cuff holds pressure for more than 2 min any change in the LMA cup
size or shape warrants disposal of LMA. Look for the pilot balloon width
if excessively inflated, it shows impending rupture .
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Mask preparation
Deflate the cuff full with a syringe after pressing it over a hard surface or
using a   deflating stool given by manufacture. The cuff should be free of wrinkles.
Using a deflating tool lengthens the life of the cuff providing superior and
consistent shape.
Apply a lubricant at the posterior surface of cuff before insertion with a care
not to press over the bowel. Water soluble gel is preferred lubrication with
lidocaine gel may decrease retching and cough but may also delay return of
reflexes and cause allergic reaction. Silicone containing gels or sprays soften and
swell the cuff.
Anaesthetic induction
An adequate general anaesthesia or topical anaesthesia is required before
insertion to blunt airway reflexes and a depth for its insertion  but not so far
tracheal intubation. Good jaw relaxation is considered as a deep plane for insertion.
Cuff inflation and assessing position and function:
For proper inflation of cuff a pressure gauge is used and cuff is inflated to up
to  60  cm  water.  Cuff  pressure  can  also  be  assessed  by  feeling  the  pilot  balloon
tension. The pilot balloon should be cylindrical and an overinflated cuff will be
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spherical. Inflation of the cuff is done gradually over three to five seconds without
holding the tube. After inflation of cuff a slight upward movement of the LMA is
seen as it seals the larynx from   pharynx . Also a swelling in front of neck is  seen.
Oro pharyngeal leak is also assessed by inflating the cuff with half of the
maximum pressure. The volume of the cuff is less important than choosing the cuff
size as large size LMA can give a better seal. The leak pressure for IPPV should
more than 20 cm H2O and for spontaneous respiration more 10 cm H2O
FIXATION:
After fixation of LMA a bite block is always kept between the molars to
prevent biting of LMA. An airway cannot be used as both LMA and airway occupy
midline. The tube should be secured with a tape , with a care not to twist it.
Intraoperative management:
Any abnormal sound heard around the LMA should alert for light plane of
anaesthesia, displacement of LMA, airway closure, closure of glottis, decrease
lung compliance or a leak in cuff. Care should be taken while trying to inflate cuff
as it further displaces it away from pharynx by increasing tension. At times
removal of air from cuff can help. Presence of fluid in tube indicates regurgitation
which is also accompanied by coughing or breath holding. At such a situation head
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end is lowered and airway suctioned after circuit disconnection. It does not warrant
removal of LMA but Endotracheal intubation should be made ready.
Emergence from anaesthesia:
Removal of LMA should be done either in deep plane or in a full awake
patient with all intact protective reflexes. LMA can be left  insitu until patient full
recovers with return of airway reflexes and phonation will give a secured airway.
Such a level can be assessed by return of swallowing reflex. If LMA is removed
during light plane aspiration of secretion can occur. It can also cause cough,
gagging or laryngospasm also removing LMA before they responds to commands
inspite of return of swallowing, incidence of gastro oesophageal reflex increases. It
can be decreased by removing LMA in deep plane. It also prevents bronchospasm
and damage to LMA. It is deserved in intra ocular surgeries but avoided in a
difficult airway patient. The disadvantages are laryngospasm, airway obstruction or
regurgitation.
Care and cleaning:
After use reusable LMA is cleaned as early as possible with   lukewarm
water and 8-10%  Sodiumbicarbonate  solution. Sodabicarb helps to remove all
secretions struck to LMA. Detergents contain irritants hence should not be used.
The tube is cleaned with a pipe cleaner brush with a care not to damage the cup
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bars. The inflation valve is kept away from any solution. Finally LMA is cleaned
in a running water dried, kept in pouch. Avoid water entering the cup. If
accidentally water enters cup, cup is held up and water is squeezed downwards.
LMA is then kept in a warming closet at 60 degree  celsius with a syringe without
a plunger in the inflation valve. Before autoclaving all air must be removed as any
residual air can expand and damage the cup/valve/pilot balloon. LMA can be
shaped into any form by bending it when it is placed for autoclaving. An open
valve can cause air to escape.
LMA can be autoclaved up to a temperature of 135 degree celsius but
temperature more than this can cause damage to LMA. It is further allowed to cool
to room temperature autoclaving damages the bond between connector and tube
but not the air tight seal. WHO  guidelines says that the fore mentioned cleaning
and sterilization or sufficient for inactivating common bacteria, fungi, viruses.
Only in a known case of spongiform encephalopathy LMA should be destroyed
after it is used.
Liquid chemical  agents   or ethylene oxide should not be used to clean or
sterilize the LMA. They are adsorbed onto the silicone and can cause pharyngitis
and laryngitis as well as shorten the LMA life.
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Figure 6 : Step 1 – Initial insertion of the laryngeal mask
Figure 7 : Step 2
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Figure 8 : Step 3
Life Span
With careful use and strict adherence to cleaning and sterilization
procedures, a laryngeal mask airway will last for a long time. The recommended
maximum number of uses by the manufacturer for the LMA-Classic is 40, but up
to 200 uses have been reported. With repeated use, there is a decrease in elastance
, an increase in cuff permeability, and a loss in strength of the airway tube. It may
be possible to exchange a malfunctioning inflation valve on an LMA.
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DESCRIPTION OF I-gel 14
It  is a new extra glottis mask airway  device  with gastric access. The I– gel
has evolved as a device that accurately positions itself over the laryngeal frame
work  providing  a  reliable    perilaryngeal    seal   .  It  also  does  not  produce
compressive  trauma.
The I-gel design
This extraglottic  airway device has no  inflatable cuff .
Advantages of I-gel are;
(i) Insertion is easy ,insertion time is less ,no need trained person to insert in
emergency airway management  even paramedical worker can insert the
device.
(ii) Tissue compression is less, less chance of ischemic events.
(iii)  It has integral bite block.
(iv) Position of the device is stable after insertion whereas in classic –LMA it
comes forward after inflating cuff  .
Parts of I-gel
1. Soft non-distendable cuff
2.  Channel for gastric access.
3.  Supraglottic blocker.
4. Oral cavity stabilizer.
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5. 15mm connector.
Figure  9 : Parts of I-gel
1. Selection of Proper size:
It is selected based upon the patient weight , sex , anatomical variation.
Larger size I-gel might be required in  following conditions; (i) if the  neck is
cylinder  shaped (ii) if there is wide laryngeal cartilages. Smaller size I-gel might
be required in following conditions (i) if the neck is broad (ii) if there is small
laryngeal cartilages . Patients  with central obesity might  not require  large size I–
gel. A size that is equal to ideal body weight for their height can be used.
If there is leak , the seal is not adequate, particularly during  controlled
ventilation, one size larger may be needed.
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2. Pre-use checks
? Make sure I –gel is not damaged before opening the package.
? Airway should be patent, there should not be any foreign particles
which might obstruct the distal  openings .
? Carefully look at the inner surface of bowl it should be smooth, free
from any particles ,there should not be any breaks ,both the channels
are intact.
? Discard the device if there is any abnormality is detected.
Pre-use preparation
1. Always wear gloves, use  a small bolus of  lubricant  which is water
based , onto the smooth outer surface , do not use silicone.
2. Do not  touch  the cuff of the device with  hands.
3. Dentures should be removed prior to attempting insertion.
Recommended insertion technique:
1. After the lubrication of  I-gel ,it should be  grasp firmly along the
integral bite block.  The I-gel cuff  should be facing towards the chin.
2.  Position; ‘sniff position’.( head extended and neck flexed).
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3. The soft tip of device should be inserted into the mouth towards the
hard palate.
4.  Move the device  continuously   along  the hard palate  until  there is
a definitive resistance.
5. In a properly placed I–gel the tip will be positioned in upper
oesophageal opening ,the cuff will be positioned  against the laryngeal
cartilage. There is no need bite block.It has to be taped.
6. There might be   ‘give-way’ when  bowl of the I-gel crosses through
the faucial pillars . We have to stop the I-gel ,do not repeatedly push
I-gel down ,  whenever  there is resistance is  felt.
     7.   Maximum three times can be attempted in one patients .
Emergence from Anesthesia
Patients with IPPV
At  the  end  of  the  surgical  procedure,  patient   should   be  reversed  .  The
patient might not be required  reversal   if there is  regular breathing pattern is
regained or  presence of  adequate protective reflexes.
Recovery and  removal
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Removal of I-gel should be done either in deep plane or in a full awake
patient with all intact protective reflexes. I-gel can be left insitu until patient full
recovers with return of airway reflexes and phonation will give a secured airway.
Such  a  level  can  be  assessed  by  return  of  swallowing  reflex.  If  I-gel  is  removed
during light plane aspiration of secretion can occur. It can also cause cough,
gagging or laryngospasm also removing I-gel before they responds to commands
inspite of return of swallowing, incidence of gastro oesophageal reflex increases. It
can be decreased by removing I-gel in deep plane. It also prevents bronchospasm
and damage to I-gel. It is deserved in intra ocular surgeries but avoided in a
difficult airway patient. The disadvantages are laryngospasm airway obstruction or
regurgitation.
CONTRAINDICATION: to use gastric channel:
1) Varices in the oesophagus.
2) Upper gastro intestinal bleed.
3) Oesophageal trauma.
4) Upper  gastro intestinal surgery.
5) Bleeding /clotting abnormalities.
REVIEW OF LITERATURE
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REVIEW OF LITERATURE
The development of the LMA began in 1981 at the Royal London Hospital,
Whitechapel, in the East End of London. A British anaesthesiologist, Dr Archie
Brain, suggested that the Goldman Dental Mask could be modified so as to be
positioned around the laryngeal inlet rather than over the nose. Similar devices had
been described an half century earlier.24
It  was  Dr.  Brain’s  belief  that  the  two  methods  by  which  the  anatomical
airway was commonly connected to an artificial airway were less than ideal. The
most elegant way to join the two involves an end to end junction at the glottis.24
The face mask falls short because it forms this connection at the mouth and nares,
and the tracheal tube goes too far, penetrating the lumen of the respiratory tree. A
high lateral pressure is then applied to the delicate epithelial surface, impairing its
specialized function and provoking undesirable autonomic responses.24
Brain’s  goal  was  to  develop  a  device  that  could  rapidly  overcome  an
obstructed airway, and yet, be simple and atraumatic to insert. Initial studies using
plaster of Paris casts of the cadaver pharynx indicated the optimal shape of the
LMA. A prototype was used on a human patient in 1981, and a successful pilot
study on 23 patients soon followed. The LMA was first used in a failed intubation
in 1983.24 Careful observations and clinical experience in more than 7,500 patients
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led to small changes in design. The availability of Propofol and the development of
a silicon cuff led to greater success in the use of the LMA.24
In recent years, I-gel, another Supraglottic airway device with some
distinctive features, has been devised that sets it apart from other competitors.
In  1995, Brimacombe J4  conducted a meta analysis of randomized
prospective  trials  in  peer  review  journals.  His  aim  was   to  find  out   the  LMA
provide any advantage over routine endotracheal tube or anatomical mask . Data
were obtained from the selected papers/abstracts about the type of comparative
study (LMA vs Tracheal Tube (TT), LMA vs facemask (FM), LMA vs FM vs TT),
the study population type and size, the type of surgery, the phase of anaesthesia,
studied ventilation mode, LMA user, success with the device and insertion
technique. The total study population was 2440 patients and the mean study
population size was 47. Advantages of LMA over tracheal tube were included:
(1) It can be placed easily and quickely, takes less time.
(2) It can be placed correctly even by paramedical workers with
minimal  experience.
(3) Minimal haemodynamic unstability at induction and emergence.
(4) Less rise in intra ocular tension.
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(5) Airway tolerance is better than endotracheal tube with minimal
anaesthetic doses.
(6) Lesser incidence of airway morbidity during emergence, Advantages
of LMA over the face mask:
(1) It can be placed correctly even by paramedical workers without any
experience.
(2  It gives better  oxygen saturation.
(3)  Hand fatigue is less.
(4)  It gives better surgical field for face , ENT surgeries with good airway
maintenance.
Disadvantages of LMA  over the Tracheal tube:
1) Oropharyngeal sealing pressor is less.
2) Incidence of gastric insufflation is high.
The author concluded that LMA gives many benefits than endotracheal tube;
(i) It can be used in resuscitation because easy placement ,takes less
(ii) It can be used in patients with cardiovascular disease because good
hemodynamic stability during induction and emergence
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(iii) It can be used in patients with glaucoma because minimal change in
intraocular pressure.
iv) It can be used in open eye surgeries, Otolaryngeal surgeries  because less
incidence of cough.
In 2008, Richez B et al26 had done a study on I–gel. It was  prospective , an
observational method.   Sample size is 71 .They included ASA physical status I–II,
Proposed  surgery was  gynaecologic surgery .  The authers concluded quality of
device was good.They were able to insert in  100% at first attempt . They got score
of very easy in more than 90%.    It could be used in IPPV ventilation because
minimal gastrointestinal insufflation , high leak pressor as well as low peak
pressure. They  also noticed less pharyngolaryngeal morbidity.
In 2008, Gatward JJ et al11 did  a  study to evaluate the no 4 I-gel  in 100
adult patients  undergoing elective surgery under general anaesthesia. Aim of the
study was to find out easiness of insertion , to assess the quality of the device, to
find out the positon by clinical method as well as fiberoptic examination, and
finally pharyngeolaryngeal morbidity. Physical status   ASA 1-3 were included in
this study .They were used target controlled infusion of drugs.
The authors concluded that the airway seal   given by the I-gel lower than
the PLMA,  but could be used in IPPV. Insertion of the device into the correct
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functional and anatomical position was easy and rapid. I–gel produces less
pharyngolaryngeal morbidity.  Author also recommended this I-gel   securing
airway in the difficult airway situations  and   during CPR.
Table - 2: Showing comparison of i-gel and c-LMA in various studies
Study-author and
year SAD
No. of
attempts
(I/11/II1)
Time of
insertion
(seconds)
A i r w a y
leak
pressure
(cmH2O)
Uppal V et al.,30 2009 I-gel 38/1 12.2 (9.7-14.3) 25c-LMA 39/0 15.2 (13.2-17.3) 22
Janakiram et al.,152009 I-gel 27/23 - 20c-LMA 43/7 - 17
Franksen H et al.,14 2009
I_gel 36/4 15 (10-60) 29
c-LMA 34/5 17 (11-180) 20
Parul Jet al.,15 2009 I-gel 24/1 3.48±1.41 -c-LMA 23/2 7.68±0.69 -
Amini S et al.,2
2010
I-gel 48/11 20 (10.4-29.6) 22.6
c-LMA 46/10 24.2 (11.6-36.8) 19.3
Helmy AM et al.,13
2010
I-gel 36/4/0 15.6 (10.72-20.52) 25.62
c-LMA 32/6/2 26.2 (8.5-43.9) 21.2
Ali A et al.,12010 I-gel 45/5 10.76±5.17 -c-LMA 47/3 10.90±5.53 -
Siddiqui AS et al., 28
2010
I-gel 45/5 - -
c-LMA 43/7 - -
Present study I-gel 37/3 22.82±4.30 23.82c-LMA 36/4 25.8±4.32 19.12
In  2009,  Uppal  V et  al30 had done  a randomized ,crossover, comparative
study between LMA unique and I–gel in anaesthetized, paralysed  patients. They
included 40 patients  posted for non emergency surgeries where they required
paralyzing agents.
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There was no significant difference between the airway leak pressures of the
two devices [median (IQR) leak pressures 25 (22–30) vs 22 (20–28) cm H2O for
the I-gel and LMA-U, respectively; (P=0.083). The median difference in the
insertion  time  between  the  two  devices  was  2.3  seconds  in  favour  of  the  I-gel.
There were three cases of difficult insertion in the I-gel group and one difficult
insertion in the LMA-U group .In this study there is no gastric insufflation , and no
adverse events were noted.
The  authors  concluded  that  that  airway  leak  pressures  and  number  of
attempts at insertion were similar between the LMA-U and the I-gel when used by
an anaesthetist experienced in the use of both SADs. There was no evidence of
gastric insufflation, gastric aspiration during the study. They were found no
significant difference in efficacy of seal and first-time successful insertion rate
between  the  I-gel  and  the  LMA-U.  The  insertion  time  for  the  LMA  –U  was
marginally longer than I-gel. They concluded that the I-gel provides a reasonable
alternative to the LMA-U for controlled ventilation during anaesthesia.
Limitation of the study:
Since the study is crossover design, they were unable to determine  which
SAD has higher airway morbidity. Hence this needs a larger non-crossover or an
observational study.
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In 2009, Janakiraman C et al15 had done  a randomised crossover study
comparing  the  I-gel  supraglottic airway and  classic  laryngeal  mask airway in
anaesthetised  spontaneously breathing patients .Sample size is 50 healthy adults.
Primary outcome was successful insertion at first attempt. Secondary outcomes
included (1) overall insertion success rate, (2) Ease of insertion, (3) Leak pressure
(4) Fibreoptic position. The size of device used was decided by the anaesthetist
based on the patient’s body weight and the manufacturer’s recommendation.
Both airways were inserted in each patient in a random order. Anaesthesia
was  induced  with  a  Propofol (iv)  target  controlled  infusion  (TCI); 7µg/ml for
induction and 3.5–5.5 µg/ml for maintenance. Once an adequate depth of
anaesthesia was achieved,  with above drug the first device was inserted according
to the manufacturer’s instructions. There are a good seal and  adequate ventilation
are assessed by  absence of any audible leak and presence of a square wave pattern
on capnography . At a fresh gas flow of 5 l/ min, the adjustable pressor limiting
valve was occluded and the minimum airway pressure at which gas leaked around
the airway device was determined (airway leak pressure) by listening for an
audible leak. The position of the first device was assessed fibreoptically, following
successful insertion, using the Brimacombe score. The initial airway was removed
after 5 min of use and replaced with the second airway, after checking the depth of
anaesthesia. Similar procedures and measurements were performed. If the insertion
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failed after two attempts, the insertion was considered as a failure and the second
device was then inserted. If there was an unacceptable leak even at low pressures
following successful insertion a larger sized device was used. The same
anaesthetist with a personal experience of > 400 c-LMAs and 20 i-gel supra-glottic
airway insertions before commencing the study, inserted all devices. The ease of
insertion was graded as(1) 0 = easy,(2) 1 = moderate (3) 2 = difficult. Records of
any pharyngo laryngeal morbidity  including airway obstruction and number of
insertions were noted. Hemodynamic parameters like  Systolic blood pressure,
heart rate and  oxygen saturations were noted at baseline, 1 and 2 min following
induction. The i-gel was  successfully inserted at the first attempt in 54%  patients
and the c- LMA was successfully inserted at the first attempt  86% of patients.  The
i-gel that was used first required to be replaced with a larger sized device in 14
patients. In  13 patients size 4 was replaced by size 5.one patient (weight 56 kg) the
size 3 was replaced with size 4. The overall success rate after two attempts and
resizing of LMA was 84% for I-gel and 92% for c-LMA. Insertion was scored as
easy in 40 cases (80%) with I-gel and 45 cases (90%) with c-LMA. The median
leak pressure was greater with the I-gel device (20 cm H2O) compared to the c-
LMA (17 cm H2O) which was clinically and statistically significant.
The study concluded that there is a considerable difference (-32%) in the
first time insertion success rate between I-gel and c-LMA. The 95% CI for the
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difference, -14 to -47% indicates that the success rate on first attempt with the I-
gel is very likely to be >12% less than with c-LMA. However, the overall success
rate after resizing of the I-gel improved with a difference of only 8%, although the
95% CI for the difference, -20 to 3%, indicates that the overall success could still
be 20% less than c-LMA which is clinically significant. Airway seal was better
with the I-gel  than the c-LMA which was statistically significant.  The number of
patients in whom the vocal cords were visible fibreoptically was significantly
different between the groups, with the I-gel scoring better than the c-LMA.
The authors concluded that I-gel with current sizing guidelines is not an
acceptable alternative to the c-LMA and recommended the manufacturers to
review the sizing guidelines to improve the success rate . However, the I-gel has a
potential advantage over c-LMA in that it has an integral tube through which
stomach contents can be aspirated and also prevent excessive inadvertent
ventilation of the stomach.
In 2009, Francksen H et al27 did  a study to compare I-gel with the LMA-
Unique in  anaesthetised adult patients  without neuromuscular blocking agents.
Sample size is eighty patients with physical status  ASA grade is  1–3 were taken
up for  study  and randomly subjected  to the i-gel  (n = 40)  or  LMA-U (n = 40)
group, respectively. They induced   with 2 mg.kg?1 Propofol and 1 µg.kg ?1
51
Remifentanil .  Anaesthesia was subsequently maintained with Propofol (4–
8 mg.kg-1 .h-1 ) and remifentanil (0.2–0.5 µg.kg-1 .h-1 ). All devices were inserted
by a single anaesthesiologist with experience using each of the study devices.
Successful insertion  was assured with capnography , bilateral chest
movements  and  auscultation . After  device placement, patients were ventilated
with a tidal volume (VT) of 7 ml.kg-1 , and  respiratory rate of 10 breaths min-1
.Following  adverse events during anaesthesia were recorded and defined as ‘’
aspiration/regurgitation, hypoxia (SpO2 < 90%), bronchospasm, airway obstruction
and dental trauma’.
Attaining adequate depth of anaesthesia was assessed with loss of eye lash
reflex.  Insertion time  was measured  from ‘touching’ the device  until the first
expiratory VT > 200 ml. Following successful placement of the I-gel, a 12 F
gastric cathter was advanced in the oesophagus through  the gastric channel . A Ph
? 2.5 was judged as indicative of gastric fluid. Airway leak pressure was
determined by closing  the expiratory valve of the breathing circle to 40 cm H2O
(fixed fresh gas flow 3 l.min-1 ) and airway  pressure when equilibrium was
reached.  Leak pressure was measured by keeping stethoscope over epigastrium .
Antomical position was confirmed by fibreoptic endoscope through the airway
tube  to  a  position  1  cm proximal  to  the  end  of  the  tube.  After  completion  of  the
study protocol, the anaesthesiologist gave a subjective grading  of the handling of
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either device, which was graded (1) Excellent,(2) Good, (3) Fair or poor, 18–24
hours after surgery  . After surgery complication were assessed .These were  (1)
Sore throat, (2) Hoarseness and (3) Dysphagia. Symptoms were graded as  (1) Nil,
(2) Moderate (3) Severe.
In the I-gel group, a successful primary airway was established in 36 patients
(90%) on the first attempt and in four patients (10%) on the second attempt. In the
LMA-U group, device insertion was successful in 34 patients (85%) on the first
attempt and in five patients (13%) on the second attempt. Time required for the
first adequate ventilation was comparable between groups (i-gel: median 15 s;
range 10–60 s; LMA-U: 17 s; 11–180 s) (p = 0.45). Subjective assessment of
handling was comparable with the i-gel and the LMA-U. In no patients did arterial
saturation decline to less than 90% . The airway leak pressure was significantly
high in i-gel group (mean 29 (5) cm H2O) compared with the LMA-U group [18
(5) cm H2O (cuff 20 ml); 20 (5) cm H2O (cuff 30 ml) and 22 (5) cm H2O (cuff 40
ml)] (p < 0.0001) Fibreoptic control of the position of the devices was significantly
better in the I-gel group. No gastric inflation occurred with the I-gel device,
whereas gastric inflation was observed in the LMA-U group in three patients
(7.5%). Gastric catheter placement was successful in all patients in the I-gel group.
Insertion of a gastric tube was very easy (first attempt) in 36 cases (90%) and easy
in four cases (second attempt) (10%). In all patients, fluid aspirated showed a
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pH?2.5 and therefore the gastric tube was assumed to be in the correct place.
Blood staining after removal of the devices occurred rarely (5%) and was
comparable between groups. There were no differences regarding postoperative
airway complication. No major adverse events occurred during the intra and
immediate postoperative period in any patient in both groups.
They  concluded that the insertion success, time required for adequate
ventilation and subjective rating of the handling of the I-gel and the LMA-U were
comparable. However, airway leak pressure was significantly higher in the I-gel
group and the fibreoptic score was also significantly better in the I-gel group. The
better seal with the I-gel device suggests an alternative to the LMA-U for positive
pressure ventilation, especially in patients where higher airway pressures are
necessary to achieve a sufficient tidal volume.
In 2009,Kannaujia A et al.17,  did  a preliminary study on I-gel . They have
taken 508 patients   with physical status 1-3 for their study . Objectives was to find
out device stability in different neck and head positions ,leak pressure ,how long
time taken for achieving successful airway, ease of insertion They  used to allow
the patients spontaneous breathing without any neuromuscular blocker . Towards
the end of the procedure just before discontinuing anaesthetic , they evaluated
stability of the device  in different head and neck positions. Placing the head and
neck in four sequential positions-1) Head on standard pillow, 2) Head rotated to
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side, 3) chin lift 4) Head without standard pillow .They  were  recorded five
consecutive tidal volumes under a constant level of anaesthetic depth.
The authors concluded that I-gel has high success rate at first insertion, easy
insertion and shorter time to achieve effective airway. They found  additional
advantages like  high seal pressure and stability of the device despite changes in
position of head and neck.
In 2009, Jindal P et al16 had  done   a  comparative  study  to  compare  the
hemodynamic effects of three supraglottic devices(i) I-gel,(ii) SLIPA (Streamlined
Pharynx  Airway  Liner),  (iii)  LMA.  The  sample  size   was   75  patients   of  either
sex. Inclusion criteria s are (i) Age  20-70 years, (ii) ASA I and II, (iii)scheduled to
undergo elective surgical procedures under general anesthesia. All the monitors
were placed and baseline reading of HR, BP, SpO2, ECG were recordeed. After,
preoxygenation with 100% oxygen, patients was  induced with  Propofol  1.5-2.5
mg/kg  slowly and  Neovec(vecuronium ) 0.1 mg/kg facilitate intubation. Above
mentioned  devices were introduced  following  the standard techniques by a single
anaesthesiologist who is noted to have considerable experience in all three
techniques. They have maintained  anesthesia  with 66% N2O ,33%  oxygen,
neovec (vecuronium) 0.015 mg/kg and morphine 0.1 mg/kg. Surgeons were
requested  to  wait  for  5 minutes after placement of supraglottic devices because
surgical stimulai might interfere with the findings. The following data were
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collected by a  blinded observer: number of intubation attempts, intubation time
(time from insertion of the intubating device into the mouth, to time of
confirmation by mechanical ventilation), mucosal trauma (blood detected on the
intubation device after use), lip or dental injury, episodes of hypoxia during
intubation (SpO2 <95%), various hemodynamic parameters like  serial heart rate,
NIBP , SpO2 and ECG recording were done following time intervals; at the time of
insertion, 1, 3 , and 5 minutes following insertion thereafter at the time of removal
and  then  1  min  after  removal.  At  the  end  of  surgery,   they  used   neostigmine  50
µg/kg  for reversing neuromuscular block and they assisted ventilation until the
patient to breathe spontaneously considering the extubation criteria. When the
patients  reflexes were regained  and  was able to open mouth on command, the
devices were removed. They found the  number of intubation attempts was similar
among groups, but intubation time was significantly longer in the LMA group.
(3.48 ± 1.41 sec with i-gel, 5.16 ±0.68 sec with SLIPA 7.68±0.69 sec with c-
LMA).
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I-gel (Group I), SLIPA (Group II), LMA (Group III)
In this study they were observed that i-gel produced less hemodynamic
changes  than  SLIPA  which  is  also  a  non  inflatable  supraglottic  device  and  the
LMA. This difference could be because SLIPA, is made of moulded plastic
(polypropylene) that does not conform to anatomic structures. During the insertion
of LMA, pressure response (i.e. increase in heart rate and arterial pressure), may be
induced by  the passage of the LMA through the oral and pharyngeal spaces,
pressure produced in the larynx and the pharynx by the inflated cuff and the dome
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of the LMA. During removal of LMA the hemodynamic response is probably
triggered by pharyngeal stimulation during reverse rotation of the cuff.
The authors concluded that i-gel effectively conforms to the perilaryngeal
anatomy despite the lack of an inflatable cuff, it consistently achieves proper
positioning for supraglottic ventilation and causes less hemodynamic changes as
compared to other supraglottic airway devices.
In  2010,  Amini  S 2 et al  compared I –gel and the performance of the
intersurgical   solus  –  laryngeal  mask  airway  and  found   the  solus  LMA  has  got
greater leak pressure , better oropharyngeal seal and good fiberoptic view then the
I -gel.
In  2010, Ansar Ali  1 conducted a study to compare the ease of insertion of
I-gel and Laryngeal mask airway (LMA).(i) In group A was  “LMA” ,(ii) group B
was “I-gel” . In this study the patients were pre-medicated with Midazolam 2.5 mg
(I/V) 15 min before shifting to operation theatre.  Pre- oxygenation was given   for
three minutes with 100% oxygen. They were induced   with  Propofol 1% 2 mg/kg
I/V . I- gel and LMA were lubricated with distilled water. After 1 minute of
ventilation with Oxygen and Sevoflurane using a face mask, LMA or an I-gel was
placed in perlaryngeal area . Maintanence of anaesthesia was carried  with O2 ,
sevoflurane and with intermittent positive   pressure ventilation (IPPV). Group A
and group B were assessed for ease of insertion of LMA and I-gel. Ease of
58
insertion LMA or I-gel was assessed  according to the following criteria(i). Easy
(no airway manipulation), (ii). Satisfactory (required less than two maneuvers),
(iii).Difficult (required more than two maneuvers).
In LMA group (Group A) easy insertion was noted in  84%  and  satisfactory
insertion was noted in 16%. While in I-gel group (Group B) exactly same
percentage was observed i.e. 84% easy and 16% satisfactory. There was no
statistically important association found in ease of insertion between I-gel and
LMA (p=1).Mean insertion time  was 10.90 ± 5.17 secs in LMA group  while that
with I-gel group was 10.76 ± 5.53 secs. There is no statistically important
difference of insertion time between two procedures (p=0.92).  They have found
manipulation of the of airway was needed in 30% of the cases with LMA and 48%
of the cases with I-gel .There were no statistical association between both groups
of airway manipulation requirements (p=0.065). First attempt insertion in LMA
group  was  94%  while  second   attempt  was  required  in  6%  of  the  cases.  In  I-gel
group, first attempt insertion was achieved in 90% and 10%  of the cases required
second  attempt. There was also statistical non-significant association between the
insertion attempt of two devices (p=0.461). Bleeding was only noted  in one case
of I-gel group. Laryngospasm  was  noted  in 2 cases; one in each. They were not
able  to secure airway with LMA occurred in 3 and with i-gel in two patients.
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They came to conclusion that their study had failed to show the superiority
of either device in (i) ease of insertion,(ii) insertion time (iii) number of attempts at
insertion.
In   2010,  Helmy13 M  et  al   compared I- gel and classic laryngeal mask
airway in an anaesthetized patients  breathing spontaneously  undergoing various
minor  elective surgeries  and found  good hemodynamics and less morbidity   in
both groups. They have  found I –gel insertion needed less skills and takes
minimal time to insert, higher leak pressure and less incidence of gastric
insuflation.
In 2010, Siddiqui AS28, et al compared  I –gel and laryngeal mask airway –
classic in anaesthetized patients with IPPV. They have found  both the devices
were able to insert   easily without  any   difficulty  .They have observed minimal
adverse events with good hemodynamic stability during insertion.  They came to
conculusion  that insertion of I-gel was easy and needed little skills as compared to
classic laryngeal mask airway at the same time results were not important
statistically. They were noticed blood staining on classic- LMA  in  18% patients
and none of them in I–gel group .Blood staining was  due to cuff pressure
produced venous  engargement, local trauma. They found both the devices were
given adequate protection from gastric aspiration and good laryngeals seal.
METHODOLOGY
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METHODOLOGY
STUDY DESIGN:
This study was conducted in Institute of Obstetrics and Gynaecology,
Chennai from August 2014 to September 2014.The study was a single blinded
,randomized, prospective comparative evaluation of the two Supraglottic airway
devices.
Study setting and population:
After obtaining institutional ethical committee clearance, eighty female
patients satisfying the inclusion criteria, undergoing short duration gynaecological
surgeries under general anaesthesia were enrolled for the study .The insertion of
the devices and collection of the data was done by author.
PATIENT SELECTION:
INCLUSION CRITERIA:
• Age : 18 years to 60 years
• ASA          : Physical status I, II
• BMI          : 20 to 25 kilogram/meter 2
• Airway      : MMS I & MMS II
• SURGERY  : Minor gynaecological surgeries(elective)
• Who have given valid informed consent.
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EXCLUSION CRITERIA:
? Not satisfying inclusion criteria
? Patient with difficult airway
? History of gastro oesophageal reflex disorder
? Patient with acute or chronic respiratory disease
? Patients with musculoskeletal abnormality affecting cervical vertebrae
? Patient with history of allergic reactions to the drugs used in the study,
materials
? History of OSA
? All emergency surgeries
? ASA physical status III & IV
The current study was designed to find out whether a functional difference
exists between classic–LMA and I–gel in terms of ease of insertion, airway leak
pressure and the complications. The sample size was calculated using G power
analysis to get an expected 30% difference between the two groups in ease of
insertion, Oropharyngeal leak pressure, and the complications.
The study patients were randomly subjected into two groups .Each group
contains 40 patients. This is done by using sealed envelope which containing the
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name of the group and the patient was asked to pick up the envelope. The envelope
was opened by senior anaesthesiologist who did not involved in this study.
Group I  - Laryngeal mask airway-Classic (n=40)
Group II  - I-gel Group (n=40)
Pre-anaesthetic evaluation was done on the evening before surgery. A
routine pre-anaesthetic examination was conducted assessing :
? General condition of the patient
? Airway assessment by mallampatti grading
? Nutrition status and body weight of the patients, height of the patients,
? Detailed examination of the cardio vascular system, respiratory
system.
The following investigation were done in all the patients:
? Haemoglobin estimation
? Urine examination for Albumin, Sugar and microscopy
? Standard 12 lead ECG
? X-ray chest
? Blood sugar, Blood urea, Serum creatinine, serum electrolytes
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 All the patients included in the study were pre medicated with tablet
alprazolam 0.5mg and tablet  ranitidine 150mg orally at bed time, the previous
night before surgery. They were kept nil orally for solids from 10 pm onwards on
previous night  and for clear fluids up to 2 hours prior to induction.
 In preparation room an 18-gauge intra venous cannula was inserted and in
operating room normal saline (500ml) was started.  Injection Ranitidine 50mg (iv),
Injection metoclopramide 10mg ( iv), Injection Glycopyrrolate 0.2mg ( im) was
give  30mins  prior  to  surgery.  In  the  operation  theatre  ECG,  Pulse  oximeter,  Non
invasive blood pressure monitors were connected and base line parameters  were
recorded and monitored throughout surgery. Optimal sniffing position is achieved
by  placing  a  8to10  cm  pillow.  ETCO2 monitor was connected after insertion of
airway. The classic LMA device was used in Group-I patients. The I-gel  was used
in Group-II patients.
 The patients were pre-medicated with injection midazolam 2mg(iv)
,injection Fentanyl 1mcg/Kg (iv). Then patients were pre-oxygenated with 100%
oxygen for three minutes via face mask with closed circuit. Pre induction baseline
cardio-respiratory parameters like Heart Rate(H.R), Blood Pressure (B.P) and
oxygen saturation (SpO2 ) were recorded . Anaesthesia was induced with Inj
Propofol 2mg/kg .  End point of induction was confirmed by loss of verbal
communication.  Modified Muzi and colleagues scoring system is used  to assess
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the tolerance of LMA insertion . According to this following parameters were
taken in to account.
(I) Jaw mobility
(a) Completely relaxed jaw score is – 1.
(b) There is mild resistance score is - 2.
(c) Able to open jaw with difficulty score is- 3.
(d) Closed jaw score is - 4.
(II) Coughing or movement
(a) Score 1- none, there is no cough or movements.
(b)   Score 2-one or two coughs.
(c)  Score 3- three or more coughs.
(d)  Score 4- bucking/movement.
(III) Others :
Spontaneous breathing ,  and Lacrimation.
Ideal score for LMA insertion was less than 2. We have to add 0.5 mg/kg of
Propofol and wait for 3 min, if there was any movement happened before insertion
or after insertion of  LMA.
The lubricated LMA classic was introduced by the classic method and the
recommended volume of air was introduced into the cuff. In patients weighing
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between 30-50 kilo gram, size 3 classic–LMA was used and in patients  weighing
between  50-  70  kg,  size  4   classic  -LMA was  used.  In  patient  weighing  between
30-60 kg, size 3 I-gel was used. In patient weighing between 50-90 kg, size 4 I-gel
was used.
The device was connected to closed circuit. The following parameters
indicates ideal placement of airway. Presence of good bilateral symmetrical chest
movements, square wave form on Capnograph, normal end tidal CO2 and stable
SPO2 (more than 95%). The device was secured with adhesive tape. Bite block was
kept in case of c-LMA and secured along with it with adhesive tape and the cuff
pressure was measured, with help of Portex Cuff Pressure monitor and ensured to
be 60 cm of H2O.  Anaesthesia  was  maintained with   using 66% N2O , 33% O2
with one to two percent Sevoflurane and without any neuromuscular blocking
agents . Immediately after insertion patients were ventilated with IPPV until
resuming spontaneous breathing and then patients were allowed to breathe
spontaneously till the end of surgery. The surgery was then allowed to commence
and intra operative complications like Bronchospasm, Aspiration were noted and
treated.
At the end of surgery nitrous oxide and Sevoflurane  were discontinued and
only O2 was given until smooth recovery of consciousness. Then the device was
removed after regaining consciousness and responding to oral  commands . The
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oral  cavity  was  examined   for  any  injuries  like   lip  ,  dental  ,tongue   and  also
device was inspected for blood staining, which indicates pharyngolaryngeal injury.
Patients were interviewed  for any post-operative  morbidity  like irritation  in
throat, difficulty in swallowing   and any change in voice after 18-24 hours.
In case of failure to insert the supraglottic airway devices properly as judged
by an audible leak or inability to achieve adequate chest expansion , the device was
removed and reinserted . Maximum three attempts were allowed and if effective
ventilation could not be achieved, the patient was excluded from the study and
proposed  surgical procedure    will be  carried out using other methods.
PARAMETERS STUDIED DURING THE PROCEDURE
1. Easiness of insertion:
Subjectively graded from 1-3
TABLE - 4
Grading of the Ease of Insertion
1
Very Easy
2 Easy
3 Difficult
Grade : 1 When there is no   assistant help  for Insertion of device.
Grade : 2 When there assistant help is needed like jaw thurst.
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Grade : 3   When  first  attempt   with  assistant  help  failed  and  second
attempt is needed .
2. Time taken for inserting the device:
It  starts   from  picking  up  the  airways   ,  to  the  time  of  confirmation  of
effective ventilation  .Time was measured  with help of stop clock and it was done
by another anaesthetist.
3. Number of Insertion Attempts:
Number of attempts required for correctly placing the each LMA was noted.
4. Airway leak pressure:
Oropharyngeal leak was determined by closing the adjustable  pressure
limiting valve(APL) of the circle system at fixed gas flow of 3 lit/min (only
oxygen)  and  recording   the  airway  pressure   at  which  equilibrium  was
reached(maximum allowed was 40cm H2O).Equlibrium was taken as the point at
which an audible sound was detected with help of stethoscope placed just lateral to
the laryngeal cartilage. Dragger machine with the provision of recording airway
pressure was used. It was measured by two persons. One person will be
auscultating the audible sound another portion will record the reading from the
monitor.
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5. Gastric insufflation:6
It was detected by epigastric auscultation with the help of stethoscope,
during intermittent positive pressure ventilation.
6.  Haemodynamic Parameters:
The following haemodynamics parameters were recorded in all patients,
? Heart rate in beats/min
? Systolic Blood pressure [SBP] in mm of Hg
? Diastolic Blood pressure [DBP] in mm of Hg
 The above haemodynamic parameters were monitored in the following time
interval---
1. Basal  preinduction
2. One minute after insertion
3. Five minute after insertion
7. Injuries:
The patient was examined  for any injury of oral cavity  like dental and lip
injury. Device was examined for blood staining which indicate pharyngolaryngeal
injury.
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8. Post-operative complication:
The patient was interviewed for any post-operative  morbidity  like irritation
in throat, difficulty in swallowing, change of voice after 18-24 hours.
Figure 10 : Portex cuff pressure manometer
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Figure 11: anaesthesia with I-gel
OBSERVATION AND RESULTS
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OBSERVATION AND RESULTS
This study has been conducted in eighty ASA physical status  I-II adult
female patients who underwent elective short duration gynecological surgical
procedures . It was ensured that they had fulfilled the inclusion criteria. All eighty
patients were included in the study.
The data was analyzed using the SPSS software version 17.0.The Qualitative
parameters such as ease of insertion, number of attempts , and the complications
were analyzed using the Pearson Chi-square test. The quantitative parameters such
as demographic data, the time taken for insertion, the oropharyngeal sealing
pressure and the hemodynamics were analyzed using the Student “t test”.  The p
Value less than 0.05  was taken as significant.
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DEMOGRAPHIC CHARACTERISTICS:
TABLE - 5
AGE DISTRIBUTION
Age
Group(yrs)
GROUP-I GROUP-II
No. of Patients Percentage(%) No. of Patients Percentage(%)
18 – 30 10 25.00 8 20.00
31 – 40 12 30.00 12 30.00
41- 50 14 35.00 19 47.50
51 – 60 04 10.00 1 02.50
TOTAL 40 100 40 100
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TABLE - 6
MEAN AGE (in Years)
Group I Group II P Value Statistical
significance
Mean age (yrs) 38.60±9.78 39.35±9.00 0.72 NS
FIGURE 12
Table 5 shows age distribution of patients in both the groups .The minimum
age in both group were 21 years. The maximum age in both group were 57 years.
The mean age  in group 1and 2 were 38.60±9.78 and 39.35±9.00 years respectively
There were no important difference between the two groups in terms of age in
years .( p= 0.72)
GROUP-II
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BODY MASS INDEX
mean  BMI
TABLE - 7
Mean BMI
Group I Group II P Value Statistical
significance
Mean BMI 22.96±0.94 22.28±1 0.14 NS
FIGURE 13
        Table 7 shows body mass index distribution of the patients. The mean
body mass index in group 1 and group 2 were 22.96±0.94 and 23.28±1.00
respectively. There were no important  difference in the body mass index  of
patients between  two groups.
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TABLE – 8
SIZE OF LMA
Size GROUP I GROUP II
No of patients Percentage(%) No of patients Percentage(%)
3 15 37.50 15 37.50
4 25 62.50 25 62.50
Total 40 100 40 100
Out of the total number of 80 patients ,size 3 LMA was used in 30 patients
and size 4 was used in 50 patients. Out of 30, size 3 LMA  15  were used in group I
and 15 were used  group II .Out of 50 ,size 4 LMA 25 were used in group I and 25
were used in group II patients.
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TABLE – 9
EASE OF INSERTION
EASE SCORE GROUP-I GROUP-II
No of Patients Percentage(%) No of Patients Percentage( %)
1 36 90.00 37 92.50
2 4 10 3 7.5
3 0 0 0 0
TOTAL 40 100 40 100
FIGURE 14
Easiness of insertion:
Out of total number of 80 patients, the insertion were very easy and easy in
73 and 7   cases respectively.  92.5% of the cases of group II had very easy
insertion  where as  90%  cases of group-I had very easy insertion. This is evident
from the table and charts .There were no cases of failure of LMA insertion in both
the groups. The easiness of insertion of both devices was comparable and the
difference was not significant statistically (p= 0.69)
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TABLE - 10
NO OF ATTEMPT
No of
Attempt
GROUP-I GROUP-II
No of Patients Percentage
(% )
No of
Patients
Percentage
(% )
1 36 90 37 92.50
2 4 10 3 7.50
3 0 0 0 0
TOTAL 40 100 40 100
FIGURE 15
Number of Attempts :
Out of  total number of 80 patients, the insertion was achieved in first
attempt  in 73 patients and second attempt was required only in 7 patients  out of
which  4  were  for  classic-  LMA  and  3  were  for  I-gel.  The  number  of  attempts
required for insertion were also comparable and the difference were not  significant
statistically   (p=0.69%)
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TABLE - 11
TIME TAKEN FOR INSERTION
Group I Group II P Value Statistic
significance
Mean time(sec) 25.88±4.32 22.82±4.30 0.002 S
FIGURE:16
Time taken for insertion :
The  mean time required for insertion of classic LMA  was 25.88 seconds as
against the mean time of 22.82 seconds required in case of I- gel.  Time taken for
insertion was also comparable and the p value was 0.002 and was statistically
significant.
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LEAK PRESSURE
TABLE - 12
MEAN AIRWAY LEAK PRESSURE
Group I Group II P Value Statistical
significance
Leak
pressure(cmH2O)
19.12±2.23 23.82±2.47 0.000 S
FIGURE 17
The mean airway leak pressure:
The mean airway leak pressure with I-gel in group 2 patients was
23.82±2.47  and with c-LMA  in group 1 was19.12±2.23  cm H2O   and was highly
significant statistically (p=0.000)
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TABLE - 13
GASTRIC INSUFFLATION:
Gastric
insufflation
GROUP-I GROUP-II
No of Patients Percentage(%) No of Patients Percentage(%)
YES 10 25.00 6 15.00
NO 30 75.00 34 85.00
TOTAL 40 100 40 100
FIGURE: 18
The gastric insufflation:
            Out of  total number of 80 patients the gastric insufflation was not
seen in 64 cases  and was seen in only  16 cases out of which 10 were for classic
LMA  and  6  was  for  I-gel.  The  gastric  insufflation  was  also  comparable  and  the
difference was not  important statistically ( p=0.26 ).
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TABLE - 14
HEART  RATE
Time intervals
(Minutes)
GROUP-I GROUP-II t-value p-value
Mean Sd Mean Sd
Pre insertion 88.62 13.89 82.28 8.16 2.49 0.688
1min post insertion 89.58 15.64 83.75 11.85 1.89 0.591
5min post insertion 84.80 14.74 80.90 9.36 1.41 0.938
                                     FIGURE:19
Hemodynamic parameters
Heart rate:
Comparison of pre insertion ,1 min post insertion ,and 5 min post insertion
heart rate in group -I and group-II cases did not show any statistically significant
difference as evident from the above table .
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TABLE - 15
SYSTOLIC BLOOD PRESSURE
Time
intervals
(Minutes)
Group I Group II t-
value
p-
valueM
ean Sd
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Pre insertion 1
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FIGURE: 20
Hemodynamic parameters
Systolic blood pressure
      Comparison of pre insertion, 1 min post insertion ,and 5 min post
insertion systolic blood pressure in group I and  GROUP II  cases did not show any
statistically significant difference either.
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TABLE - 16
DIASTOLIC BLOOD PRESSURE
Time intervals
(Minutes)
Group-I Group-II t-value p-value
Mean Sd Mean sd
Pre insertion 77.72 7.66 77.00 8.54 0.40 0.69
1min post insertion 77.72 10.83 77.12 14.94 0.21 0.84
5min post insertion 72.98 8.18 74.42 17.63 0.49 0.63
FIGURE: 21
Hemodynamic parameters
Diastolic blood pressure:
       Comparison of pre insertion, 1 min post insertion, 5 min post insertion
Diastolic blood pressure in classic LMA and I-gel cases had not showed any
significant difference statistically.
All the above mentioned parameters (HR, SBP, DBP)  were found to have
marginal peak effect at 1 min post insertion in both the groups.
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TABLE - 17
COMPLICATIONS
COMPLICATIONS GROUP-I GROUP-II
N % N %
No    Complications 23 57.5 29 72.5
Lip injury 5 12.5 1 2.50
Post removal cough 4 10.00 0 0
Postoperative nausea, vomiting 1 2.50 2 5.00
Dysphagia 0 0 2 5.00
Blood staining on airway device 7 17.50 6 15.00
Total 40 100 40 100
Out of total number of 80 cases, 52 cases did not have any complications at
all. Out of 28 cases in which complications were observed. 17 cases had
complication in group I, 11  cases had complications in group II.
6 cases  had lip  injury, 4 cases had post removal cough, 3 cases had nausea
and vomiting, 2 cases had dysphagia. 13 cases had blood stain on airway device.
Out of the 6 cases of lip injury 5  cases were from group I and 1 case  was
from group II.
Out of 4 cases, with post removal cough on the LMA 4 were from group I.
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Out of 3 cases with post of nausea and vomiting 1 was from group I while 2
were from group II.
Out  of  13  cases  of  blood  staining  on  airway  7  were  from group  I,  while  6
were from group II.
None of the cases had laryngospasm, pulmonary edema during  intra
operative or post operative period. In terms of development of either intra op or
post op complications, the difference between the two groups was not found to be
statistically significant
DISCUSSION
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DISCUSSION
This study was conducted in Institute of Obstetrics and Gynaecology (MMC,
Chennai) between August 2014 to September 2014 and involved 80 patients in
ASA I-II physical status. They were randomized in to 2 groups: Group –I-(
Classical LMA ) and  Group –II (I–gel)   and following parameters were analysed .
1) Ease of insertion
2) Number of attempts
3)  Time of insertion
4) Airway Leak pressure
5) Gastric insufflation
6)  Hemodynamic parameters
7) Airway injuries
8) Complications
Demographic criteria:
Both the groups are comparable and there is no statistically important
difference regarding   age, weight, body mass index.
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Ease of insertion :
One of the primary objectives was to compare the ease of insertion between
the two devices. The grading of insertion was done similar to the study conducted
by Siddiqui et al.28
In our study, the ease of insertion of classic -LMA was very easy (score 1) in
36 (90%) patients and easy  (score 2) only in 4 (10%) patient. In group 2 insertion
of I -gel was  score 1 and score 2 in 37(92.5%) and 3 (7.5%) patients respectively.
There is no statistically important difference between the two groups with
respect to ease of insertion (p>0.05). The insertion of I-gel was found
comparatively easier and required minimal skill as compared to Classical LMA.
The group two device  having a non inflatable cuff and firm in consistency was
much easier for insertion as compared to LMA.
In our study the easiness of insertion of the device was compared with   the
study conducted by Ali A.1 Siddiqui.28 Janakiram.15 who also did not find any
statistically significant difference. Insertion of I-gel in our study was similar to
Richez B et al.26study, who graded insertion of no-4 I-gel as very easy in 93% (66
of 71) patients and easy in remaining 7% (5 of 71) patients. Insertion of c-LMA in
our study was comparable with Janakiram et al.15 study where 90% (45 of  50) c-
LMA insertions were easy insertions.
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Number of attempts
TABLE – 18
Showing number of attempts of insertion in various study
In this study, insertion of group 2 airway device was successful in 1st
insertion  in  92.50%  cases  as  Compared  to  90%  first  time  insertion  with  c-LMA.
Airway manipulation like jaw thrust was required during second attempt insertion
Study-author
and year
SAD
1st attempt
insertion
no. (%)
2nd attempt
insertion
no. (%)
3rd
attempt
insert
ion
p value
Uppal V i-gel 38 (97.4%) 1 (2.6%) -
_
et al.,30 2009 c-LMA 39 (100%) 0% -
Janakiram i-gel 27 (54%) 23 (46%) -
et al.,15 2009 c-LMA 43 (86%) 7 (14% ) - 0.001 (HS)
Franksen H i-gel 36 (90%) 4 (10%) -
et al.,10 2009 c-LMA 34 (85%) 5 (13%) - -
Amini S i-gel 48 (80%) 11 (18%) -
et al.,2 2010 c-LMA 46 (77%) 10 (17% ) - 0.73 (NS)
Helmy AM i-gel 36 (90%) 4 (10%) -
et al.,13 2010 c-LMA 32 (80%) 6 (15%) 2 (5%) -
Siddiqui AS i-gel 43 (86%) 7 (14%) -
0.54(NS)c-LMA 45 (90% ) 10% -et al.,282010
i-gel 37(92.50) 3(7.50%) -
Present study 0.092 (NS)
c-LMA 36 (90%) 4(10%) -
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in  7.5%  of  patient  of  I-gel  insertion  and  10%   patients  with  c-LMA  insertions.
Very similar results were found in studies conducted by Helmy AM et al.13 Uppal
V et al.30 Franksen H.10 Amini S .2 Siddiqui AS .30 as shown in table .
In Janakiram et al.15 study, the success rate with first time I-gel insertion was
only 54%, and with c-LMA of 86% which was statistically highly significant. This
is because the author has used large size I-gel in 14 patients due to presence of
audible leak  and hence required second attempt. However, in our study we did not
have such problem and comparable between both the devices.
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Time of insertion
TABLE - 19 : Showing the time of insertion of SAD in various studies
Study-author and
year
Time of insertion
(seconds) p value
Uppal V et al.,30 2009
I-gel 12.2 (9.7-14.3)
0.007 (HS)
c-LMA 15.2 (13.2-17.3)
Franksen H et al.,4 2009
I-gel 15 (10-60)
0.45 (NS)
c-LMA 17 (11-180)
Parul Jet al.,25 2009
I-gel 3.48±1.41
<0.05 (S)
c-LMA 7.68±0.69
Amini S et al.,2 2010
I-gel 20 (10.4-29.6)
>0.05 (NS)
c-LMA 24.2 (11.6-36.8)
Helmy AM et al.,13 2010
I-gel 15.62 (10.72-20.52)
0.0023 (HS)
c-LMA 26.2 (8.5-43.9)
Ali A et al., 12010
I-gel 10.76±5.17
0.92 (NS)c-LMA 10.90±5.53
Present study
I-gel 22.82±4.30
0.002 (HS)
c-LMA 25.88 ±4.32
The time for insertion was considered according to the study conducted by
Helmy AM et al.13 from picking up the device to confirmation of effective
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ventilation by bilateral chest movement, square wave pattern capnography, normal
range end tidal CO2 and stable arterial SpO2 (>95%).10,2
In our study, the time for insertion of I-gel (22.82s) was shorter compared to
Classic-LMA (25.88 s) which was highly significant statistically (p=0.002).
The I-gel Supraglottic airway device is made of thermoplastic elastomer and
has no cuff to be inflated after its insertion, hence requires less time for successful
insertion as compared to Classic-LMA which has a cuff to be inflated after its
insertion.
Consistent with our results, Helmy AM et al.13 Uppal  V et  al.30 Parul   J  et
al.5 also had significant difference in the insertion times as shown in Table . In
Franksen H et al.10 Amini S et al.2 Ali A et al.1 studies, though the mean time for I-
gel insertion was clinically shorter as compared to c-LMA, it was not  statistically
significant.
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Airway leak pressure
TABLE - 20
Showing airway leak pressure in various studies
Airway leak pressure detection was performed in a similar manner done by
Uppal V et al.30 in their study. The difference in the oropharyngeal sealing pressure
between group I and group II were statistically significant in our study (p=0.000)
Study-author and year SAD
Airway leak
pressure
(cm H2O)
p value
Uppal Vet al.,30 2009
I-gel            25
0.084 (NS)
c-LMA            22
Janakiram et al.,15 2009
I-gel            20
0.023 (S)
c-LMA            17
Franksen H et al.,10 2009
I-gel            29
0.0001 (HS)
c-LMA            20
Amini S et al.,2 2010
I-gel 22.6
0.02 (S)
c-LMA 19.3
Helmy AM et al.,13 2010
I-gel 25.62
0.0016 (HS)
c-LMA 21.2
Present study
I-gel 23.82
0.002 (HS)
c-LMA 19.12
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similar  to  the  previous  studies  of  Janakiram  .15 Franksen  H  .10 Amini  S  .2 and
Helmy AM .13 as shown in the above table .
Airway leak pressure of I-gel in our study was comparable with Uppal V et
al.30 and Helmy AM et  al.13 studies and of  c-LMA with Amini  S et  al.2 study,  as
shown in Table.
Haemodynamic changes:
While inserting and removing  the airway devices ,the hemodynamic
changes are produced because of mechanical contact between device and
oropharyngeal structures, pressure  over the larynx and pharynx   produced by
inflated cuff and dome of airway device .16
The  haemodynamic parameters were monitored in the following time
interval – Basal before isertion,, 1 minute after insertion, 5 minutes after insertion
.16
In  our  study,  there  was  no  important  difference  between   two  groups  with
regarding to all hemodynamic parameters. The results of our study were similar to
the  studies  done  by  Helmy  AM  et  al.13 Franksen  H  et  al.15 who in their studies
found no significant difference between two groups regard to all hemodynamic
parameters.  Jindal P et al.16 in their study observed that I-gel produced less
haemodynamic changes compared to other Supraglottic airway devices. Since I–
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gel can change its shape according to temperature, At normal body temperature it
correctly fits into  perilaryngeal structures, does not produce much pressure over
anatomical structures, hence produce less hemodynamic changes when compared
to  Classic-LMA which because of an inflatable cuff can produce more
haemodynamic changes.
Injuries
The inflatable Supraglottic airway devices during insertion, the deflated
leading edge of the mask can catch the epiglottis edge and cause it to down-fold or
impede proper placement beneath the tongue and can cause pharyngeal injury.35
Inflatable masks also have the potential to cause tissue distortion, venous
compression and nerve injury.23
In  our  study,  at  the  end  of  procedure,   the  patients  were  inspected  for  any
trauma to oral cavity ,  which is similar to study done by Siddiqui AS et al.28 Lip
injury was noted in 5 patients in group I  out of 40 and in 1 patient out of 40 in
group II. However the incidence was not statistically significant. Similar results
have been observed in studies done by Helmy AM et al.13 In the study conducted
by Siddiqui AS et al.,28blood on device was noted in 18% cases of LMA group
while none in the I-gel group which was statistically significant. The authors
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attributed the cause might be due to pressure  produced   by inflatable cup
,resulting in trauma to adjoining structures .
Postoperative complications
The patients were interviewed for any postoperative complications like sore
throat, dysphagia and hoarseness after 18-24 hours.2, 32
Only 2 patients in group II had developed dysphagia post operatively
compared to none  in group I.
Our results were consistent with the studies done by Siddiqui AS et al.28
Helmy AM et al.13Fanksen H et al.10 where the  difference between two
groups  regarding postoperative morbidity was not statistically important. But there
was higher incidence of nausea and vomiting in Classic–LMA group due to more
incidence of gastric insufflation.13
Keijzer C et al.18 in their study compared the post operative throat and neck
complications between LMA and i-gel.  They found there were  more incidence  of
throat irritation and pain during swallowing  at first hour, first day, and  second day
in the group I compared with the group II. And also more incidence of neck pain
noted  in  c-LMA  group.  Since  there  is  no  cuff  in  I–gel,  it  causes  less  number  of
postoperative throat and neck pain.
SUMMARY
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SUMMARY
A study entitled “Prospective, randomized, study to compare classic –LMA
and  I-gel in anaesthetised spontaneously breathing patients undergoing      minor
gynaecological surgeries”- was undertaken in Institute of Obstetrics and
Gynaecology, Chennai, during the period of August 2014 to September 2014. The
study was undertaken after obtaining ethical committee clearance as well as
informed consent from all patients.
Eighty  patients, scheduled for various elective minor gynaecological
surgical procedures ,under  general  anaesthesia who meet the inclusion criteria
were included in this study.  The  study  population was  randomly divided into
two groups  with 40 patients in each group.
Group I  - Classic LMA (n=40)
Group II  - I –gel   (n=40)
Pre-anaesthetic evaluation was done on the evening before surgery. A
routine pre-anaesthetic examination and routine investigations were done. On the
day of surgery after recording the baseline readings, the patients were pre
medicated with injection Midazolam 2 mg (iv), injection Fentanyl 1 mcg/kg. Then
patients were preoxygenated with 100% oxygen for 3 minutes via a face mask with
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closed circuit.   Anaesthesia was induced with injection Propofol 2 mg/kg body
weight. End point was loss of verbal communication and loss of eye-lash reflex.
Modified muzi and colleagues scoring system was used to assess the tolerance of
LMA insertion. Ideal score for LMA insertion is less than 2. Additional 0.5 mg/kg
injection Propofol was given if the score was more than 2 or on any movement and
after 3 minute the allotted device was inserted according to the manufacturer’s
instructions.
An effective airway was confirmed by bilateral symmetrical chest
movement, square waveform on capnograph, normal range end tidal CO2 and
stable arterial SpO2 (>95%). Device was secured with adhesive tape. Bite block
was kept in case of LMA-classic and secured along with it with adhesive tape.
Anaesthesia was maintained using 66% nitrous oxide and 33% of oxygen
with 1-2% Sevoflurane without any neuromuscular blocking agents .The patients
was  allowed  to  breath  spontaneously.    At  the  end  of  surgery  the  device  was
removed after they were fully awake and obeys commands . The patients were
inspected for any injury of the lips, teeth or tongue and the device for blood
staining. The patients were interviewed for any postoperative complications like
sore throat, dysphagia and hoarseness 18-24 hours.
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TABLE- 21
Showing the results obtained in the present study
GROUP I GROUP II
Mean age in years 38.60 39.35
Mean BMI 22.96 23.28
Ease of insertion(1/2/3) 36/4/0 37/3/0
Number of attempts (I/II) 36/4 37/3
Duration of insertion (seconds) 25.88 22.82
Airway leak pressure(cmH2O) 19.12 23.82
Gastric insufflation(cases) 10 6
Lip injury( cases) 5 1
Blood on device(cases) 7 6
Post of sore throat(cases) - -
Post op dysphagia(cases) 0 2
Post op nausea ,vomiting(cases) 1 2
The insertion of I-gel was very easy in 37 patients and was easy in 3
patients. The insertion of c-LMA was very easy in 36  patients, and easy in 4
patients .The first time insertion rate was more with I-gel as compared to c-LMA.
Airway manipulation like jaw thrust was required in 4 patients of c-LMA group.
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The mean duration of insertion was significantly lower with I-gel than with c-
LMA. The mean airway leak pressure was more with I-gel compared to c-LMA.
                 Both devices are easy to insert. There was no significant
haemodynamic changes between I-gel and c-LMA with respect to heart rate, blood
pressure and arterial oxygen saturation (SpO2 ).
                 Postoperative complications were not significantly different
between I-gel and Classic-LMA. The I-gel provides a better airway sealing
pressure compared to c-LMA.
CONCLUSION
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CONCLUSION
Both  classic  LMA  and  I-gel  can  be  used  safely  and  effectively  during
general anaesthesia with spontaneous breathing in selected patients. Both classic-
LMA and I-gel did not cause any significant alterations in the hemodynamic status
of patients. Both the devices were easy to insert. But insertion of I-gel was easier
and more rapid than insertion of Classic–LMA. Leak pressure was
significantly higher with I-gel than with Classic-LMA. I-gel has low
pharyngeolaryngeal morbidity rate as compared to Classic LMA.
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COMPARATIVE STUDY BETWEEN I-GEL
AND CLASSICAL LMA
Date: Roll No: Airway Device:
Name: Age: Sex: IP No:
Diagnosis: Surgical Procedure:
Ht: CVS: Hemoglobin:
Wt: RS: Blood Sugar:
BMI: Blood urea :
Creatinine:
Airway: MPC:
Pre OP Assessment: I/II
H/o.Any Co/morbid Illness:
H/o.Documented difficult airway, Previous surgery, Drug Allergy,
Latex Allergy, H/o. Obstructive Sleep Apnea.
Duration of Surgery
Start Time: End Time: Total Duration:
MEASURES  OF STUDY OUTCOME
1. Ease of Insertion : very easy / easy/ Difficult
2. Number of Attempts :
3. Time Taken for Insertion :
4. Leak Pressure :
5. Gastric insufflation                     :
6.  VITALS: HR SBP DBP          PO2         ETCO2
Pre insertion of device
Post insertion of device
1 min
5 min
7. Complications
Post Extubation Cough :
Breathing Holding :
Blood I-gel/ LMA :
Lip and Dental Injury :
Sore Throat
Dysphagia
Dysphonia
Numbness of Tongue/
Oropharynx
Blocked or painful ears
Reduced hearing
Neck Pain
PATIENT CONSENT FORM
Study title  : “Prospective, randomized study comparing Classic
LMA and I-gel in anaesthetised spontaneously
breathing patients undergoing  minor gynaecological
surgeries”
Study centre    :      Department of Anaesthesiology,
                               Institute of Obstetrics and Gynecology
Rajiv Gandhi Govt. Hospital, Egmore, Chennai.
Participant name :  Age:                         Sex:
I.P.No:
I confirm that i have understood the purpose of procedure for the above
study. I have the opportunity to ask the question and all my questions and
doubts have been answered to my satisfaction.
I have been explained about the pitfall in the procedure.  I have been
explained about the safety, advantage and disadvantage of the technique.
I understand that my participation in the study is voluntary and that i
am free to withdraw at anytime without giving any reason.
I understand that investigator, regulatory authorities and the ethics
committee will not need my permission to look at my health records both in
respect to current study and any further research that may be conducted in
relation to it, even if i withdraw from the study. I understand that my identity
will not be revealed in any information released to third parties or published,
unless as required under the law. All results from the above study will be kept
confidentially. I agree not to restrict the use of any data or results that arise
from the study.
Time:
Date: Signature / thumb impression of patient
Place:                                          Patient name:
Signature of the investigator:
Name of the investigator: A.Rajendran
INFORMATION TO PARTICIPANTS
Investigator                : Dr.A.Rajendran
Name of the participants :
Title             :  “A prospective, randomized study comparing Classic
 LMA and I-gel in anaesthetised spontaneously
breathing patients undergoing  minor gynaecological
surgeries”
You are invited to take part in this research study. We have got
approval from the IEC. You are asked to participate because you satisfy the
eligibility criteria. We want to compare and study the safety and efficacy of
What is the purpose of the research :
LMA is emerging as a replacement for endotracheal tube for giving
general anaesthesia. This study compares the I-gel and classical LMA in
terms of OSP, hemodynamic parameters and complications assess which
LMA gives a better fit around the larynx.
The study design:
All the patients in the study will be divided into two groups randomly
and will be premedicated. General anaesthesia will be induced with
midazolam, fentanyl and propofol. First group will have classic LMA
insertion. Second group will have I-gel insertion. The ease,time,number of
attempts of insertion of the LMA will be noted. After this the OSP will be
measured by closing the APL valve and keeping the flowrate at 3 liters per
min and noting the airway pressure at which an audible leak can be heard
(not exceeding 40cm of H2O at cuff pressure of 60cm of H2O). At the end of
the operation anaesthetic agents will be discontinued, allowing smooth
recovery of consciousness. The devices will be removed after you have
regained consciousness and respond to verbal command. complications if any
will be noted and treated. All results of this study will be kept confidentially.
Benefits:
This study will help us in deciding which LMA is best suited for
giving general anaesthesia from functional as well as anatomical aspects.
Discomforts and risks:
Post op sore throat, cough, hoarseness of voice, laryngospasm have
been reported in previous studies but can be managed effectively. Post op
nausea and vomiting can be prevented by giving antiemetic
inj.metoclopromide 10 mg half an hour before surgery.
Time:
Place:
Date:
Signature of investigator                      Signature of participant/
Name: Dr.A.Rajendran Thumb Impression
Name:
MASTER CHART
MPC - Mallampati grading
WT - Weight in kg
HT - Height in cm
BMI - Body mass index
Surg - Name of surgery
Gas - Gastric insufflation
FRA CURR         - Fractional curettage
Aub - Abnormal uterine bleeding
Dub - Dysfunctional bleeding
EUA - Evaluation under anesthesia
S&E - Suction and Evacuation
The Cur - Therapeutic curettage
S 
N
O
N
A
M
E
A
G
E
AS
A
MPC
WT(KG)
HT(CM)
BMI
DIAGNOSIS
SURGERY
SAD
SIZE
EASINESS OF INSERTION
NO. OF ATTEMPT
TIME IN SECONDS
 LEAK PRESSURE
GASTRIC INSUFFLATION
COMPLICATIONS
PRE INSERTION HR
PRE INSERTION SBP
PRE INSERTION DBP
POST INSERTION 1 MINT HR
POST INSERTION 1 MIN SBP
POST INSERTION 1 MIN DBP
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